Pharmaceutical company Boehringer Ingelheim recently presented encouraging data regarding its investigational drug tiotropium delivered through the company’s Respimat inhaler, for the treatment of asthma. The data was presented at the 2015 American Academy of Allergy, Asthma & Immunology ... Read more